About Daclahep Daclatasvir Dihydrochloride 60mg Tablets
What Is Daclahep?
Daclahep Contains Daclatasvir, a Medicine Used to Treat Chronic (Lasting a Long Time) Hepatitis C Genotype 1 or Genotype 3 Infection in Adults. Daclahep Must Be Taken in Combination With Sofosbuvir, or With Sofobuvir and Ribavirin. It Must Not Be Taken by Itself.
How Is Daclahep Used?
Follow the Dosage Instructions Given to You by Your Doctor, Including Dosage Information About Sofosbuvir and Ribavirin.
For the Majority of Patients, One Tablet of Daclahep Will Be Taken Daily for a Period of 12 Weeks.
Adverse Effects
The Most Serious Side Effect of Daclatasvir and Sofosbuvir Occurs in Patients Taking Amiodarone. Bradycardia (Slow Heart Rate) Can Occur. If You Are Taking These Three Drugs and Notice Any of the Following, Contact Your Doctor Immediately.
- Fainting or Near-fainting
- Dizziness or Lightheadedness
- Not Feeling Well
- Weakness
- Tiredness
- Shortness of Breath
- Chest Pain
- Confusion
- Memory Problems
Common Side Effects Are Generally Only Mild and Temporary. You May Notice Headaches and Tiredness, and if You Are Taking Ribavirin Anemia (Low Red Blood Cell Count) and Nausea.WarningsDaclatasvir Should Never Be Taken on Its Own. It Must Be Used in Combination With Other Antiviral Medicines. Make Sure to Read Any Safety Information About Sofobuvir and Ribavirin if You Are Taking These With Daclatasvir.
- Prior to Beginning Treatment With Daclatasvir, Tell Your Doctor if:
- You Have Had Liver Problems and/or Liver Transplant
- You Have Had Heart Problems
- You Are Taking Any Other Prescription or Non-prescription Medicines
- You Are Pregnant or Your Partner Is Pregnant
- You Are Trying to Become Pregnant or Your Partner Is Trying to Become Pregnant
Comprehensive Hepatitis C ManagementDaclahep Daclatasvir Dihydrochloride 60mg Tablets are designed to support effective treatment of chronic Hepatitis C infection. As a direct-acting antiviral, Daclatasvir interferes with the replication of the hepatitis C virus, improving patient outcomes when used as indicated by a healthcare provider. This medication is manufactured in India and meets global pharmaceutical standards.
Professional Guidance for Safe UsageThe dosage and administration of Daclahep tablets should always be determined by a physician. Your doctor will base the course on your specific health needs, potential drug interactions, and any other ongoing treatments. Strict adherence to prescribed guidelines is crucial to maximize therapeutic benefits and minimize risks.
FAQ's of Daclahep Daclatasvir Dihydrochloride 60mg Tablets:
Q: How should Daclahep Daclatasvir Dihydrochloride 60mg Tablets be taken?
A: Daclahep tablets should be swallowed whole with water, exactly as directed by your physician. Dosage and combination with other medications are determined by your doctor according to your individual medical profile.
Q: What is the primary use of Daclahep Tablets?
A: These tablets are primarily used to treat chronic Hepatitis C infection as part of a combination antiviral therapy. They inhibit the virus's ability to replicate, aiding in better disease management.
Q: When should I take Daclahep Daclatasvir Tablets?
A: Take the tablets at the same time each day as per your physician's instructions. Maintaining a consistent schedule supports effective levels of the drug in your system for optimal results.
Q: Where are Daclahep Tablets manufactured and available?
A: Daclahep tablets are manufactured, exported, distributed, and supplied in India by certified pharmaceutical companies. They are available across India and may also be accessible in other countries through authorized importers and exporters.
Q: What is the process for obtaining Daclahep Tablets?
A: Daclahep tablets require a prescription from a licensed healthcare provider. Once prescribed, you can purchase them from authorized pharmacies, distributors, or through hospital supply channels.
Q: What are the benefits of using Daclahep Daclatasvir Tablets?
A: When used correctly, these tablets significantly reduce the Hepatitis C viral load, improve liver health outcomes, and lower the risk of long-term complications. Their inclusion in combination therapy increases the likelihood of achieving viral clearance.